A higher triglyceride-glucose (TyG) index has been related to an increased
incidence of stroke in community population. A meta-analysis was performed to
evaluate the association between TyG index and prognosis in patients with acute
ischemic stroke (IS). Observational studies, which evaluated the influence of
TyG index on functional outcome and mortality in patients with acute IS were
retrieved by search the PubMed, Embase, Web of Science, Wanfang and China
National Knowledge Infrastructure databases from inception to February 20, 2022.
Two authors independently collected the data of study characteristics and
outcomes. A random-effect model was used to pool the results via incorporating
the influence of possible between-study heterogeneity. Eight cohort studies
involving 34 076 patients with acute IS contributed to the study. Pooled results
showed that a higher TyG index was independently associated with increased risks
of all-cause mortality (OR: 1.60, 95% CI: 1.19–2.15,
p=0.002; I2=78%) and poor functional outcome (OR: 1.37,
95% CI: 1.11–1.69, p=0.004; I2=71%).
Further sensitivity analyses by excluding one cohort study at a time showed
consistent results (p all<0.05). Subgroup analyses showed similar
results in prospective and retrospective cohort studies, in non-diabetic and
diabetic patients, and in studies with follow-up durations within 3 months and
of 12 months (p for subgroup analyses all>0.05). In conclusion, higher
TyG index is a predictor of all-cause mortality and poor functional outcome in
patients with acute IS, and TyG index may be useful for prognostic evaluation in
these patients.